Centessa Pharmaceuticals's total assets for Q1 2024 were $328.17M, a decrease of -13.04% from the previous quarter. CNTA total liabilities were $113.01M for the fiscal quarter, a -4.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.